Literature DB >> 32289665

LncRNA LINC-PINT increases SOCS1 expression by sponging miR-155-5p to inhibit the activation of ERK signaling pathway in rheumatoid arthritis synovial fibroblasts induced by TNF-α.

Jing Wang1, Qing Zhao2.   

Abstract

Rheumatoid arthritis (RA) is a systemic and chronic autoimmune disease associated with altered gene expression in synovial tissue. Long intergenic non-protein encoding long-chain RNA p53-induced transcript (LncRNA LINC-PINT) has been reported to be involved in multiple physiological and pathological processes. However, the role of lncRNA LINC-PINT in RA is rarely mentioned. To investigate the mechanism of LINC-PINT in RA, we constructed a RA model using TNF-α-induced method to explore the downstream effector and signaling pathway. We found that LINC-PINT was downregulated in RA tissues and TNF-α stimulated RA cells. And overexpression of LINC-PINT could inhibit cell proliferation and invasion induced by TNF-α through downregulating the levels of IL-1β and MMPs and inhibiting the activation of ERK pathway. Using bioinformatics analysis and RNA Binding Protein Immunoprecipitation (RIP) assay, we verified that LINC-PINT directly interacted with miR-155-5p, and miR-155-5p could regulate the expression of SOCS1. Whereas, downregulation of miR-155-5p inhibited cell growth and invasion. Overexpression of miR-155-5p could reverse the inhibitory effect of LINC-PINT induced by TNF-α. Furthermore, silencing SOCS1 promoted cell proliferation and invasion, upregulated the expression of IL-1β and MMPs, and activated ERK pathway, while overexpression of LINC-PINT could reverse the control of knocking down SOCS1. In conclusion, we revealed that LINC-PINT suppressed TNF-α induced cell proliferation and invasion which might be induced through downregulating miR-155-5p, influencing the expression of SOCS1, IL-1β and MMPs and inactivating ERK signaling pathway.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytokine signaling 1; Rheumatoid arthritis; Tumor necrosis factor α; lncRNA LINC-PINT; miR-155-5p

Mesh:

Substances:

Year:  2020        PMID: 32289665     DOI: 10.1016/j.intimp.2020.106497

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  8 in total

1.  LncRNA LOC100912373 modulates PDK1 expression by sponging miR-17-5p to promote the proliferation of fibroblast-like synoviocytes in rheumatoid arthritis.

Authors:  Chang Fan; Xiaoya Cui; Sen Chen; Shaopeng Huang; Hui Jiang
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

Review 2.  Potential Molecular Mechanisms of Plantain in the Treatment of Gout and Hyperuricemia Based on Network Pharmacology.

Authors:  Pei Liu; Huachong Xu; Yucong Shi; Li Deng; Xiaoyin Chen
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-22       Impact factor: 2.629

Review 3.  The non-coding RNA interactome in joint health and disease.

Authors:  Shabana A Ali; Mandy J Peffers; Michelle J Ormseth; Igor Jurisica; Mohit Kapoor
Journal:  Nat Rev Rheumatol       Date:  2021-09-29       Impact factor: 20.543

Review 4.  LncRNAs and Rheumatoid Arthritis: From Identifying Mechanisms to Clinical Investigation.

Authors:  Wentao Huang; Xue Li; Chen Huang; Yukuan Tang; Quan Zhou; Wenli Chen
Journal:  Front Immunol       Date:  2022-01-11       Impact factor: 7.561

Review 5.  A Network Biology Approach to Understanding the Tissue-Specific Roles of Non-Coding RNAs in Arthritis.

Authors:  Shabana Amanda Ali; Chiara Pastrello; Navdeep Kaur; Mandy J Peffers; Michelle J Ormseth; Igor Jurisica
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-03       Impact factor: 5.555

Review 6.  miR-155: An Important Role in Inflammation Response.

Authors:  Jingyan Hu; Songli Huang; Xiaoli Liu; Yuan Zhang; Shengli Wei; Xiuhua Hu
Journal:  J Immunol Res       Date:  2022-04-06       Impact factor: 4.818

7.  Potential molecular mechanisms of Ermiao san in the treatment of hyperuricemia and gout based on network pharmacology with molecular docking.

Authors:  Yin-Hong Geng; Jia-Hui Yan; Liang Han; Zhe Chen; Sheng-Hao Tu; Lin-Qi Zhang; Chun-Dong Song; Feng-Yang Duan; Ya-Fei Liu
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

8.  MiR-19b-3p Attenuates Chondrocytes Injury by Inhibiting MAPK/NF-Κb Axis via Targeting SOCS1.

Authors:  Liang Shi; Liang Duan; Dapeng Duan; Yayi Fan; Honghai Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-11       Impact factor: 2.650

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.